轻度至中度碘缺乏孕妇的碘摄入与甲状腺功能相关
基于挪威母婴队列2910名孕妇的横断面研究,评估膳食碘摄入和尿碘浓度与甲状腺功能的关系。结果显示尿碘浓度与FT3、FT4呈负相关,而碘摄入问卷未显示关联;妊娠12周后开始补碘与甲状腺激素降低相关。轻中度碘缺乏可能影响孕期甲状腺功能,但差异较小。
要点
- 尿碘浓度与FT3、FT4呈负相关,提示碘缺乏影响甲状腺功能。
- 膳食碘摄入问卷未显示与甲状腺功能指标的关联。
- 妊娠12周后补碘可能与甲状腺激素降低相关。
核心结论
- 轻中度碘缺乏可能影响孕期甲状腺功能。
- 但差异较小,正常参考范围或可基于轻度碘缺乏人群数据确定。
- 妊娠12周后开始补碘可能暂时抑制甲状腺激素产生或释放。
研究设计与样本
- 基于人群的妊娠队列研究,纳入2910名挪威母婴队列孕妇。
- 采用食物频率问卷评估膳食碘摄入,并检测点尿碘浓度。
- 检测血浆甲状腺激素和抗体,样本采集于平均孕周18.5(标准差1.3)。
主要发现
- 食物来源碘摄入中位数为121 μg/天(四分位距90, 160)。
- 40%报告孕期使用含碘补充剂。
- 未使用补充剂者尿碘浓度中位数59 μg/L,采样时使用补充剂者为98 μg/L,均提示轻中度碘缺乏。
- 食物频率问卷碘摄入与结局指标无关联,尿碘浓度与FT3(p=0.002)和FT4(p<0.001)呈负相关。
- 妊娠12周后开始补碘与FT4降低相关(p=0.027),FT3降低无统计学意义(p=0.17)。
关键数值与推荐
- 未使用补充剂孕妇尿碘浓度中位数59 μg/L,使用补充剂者98 μg/L。
- TSH、FT4、FT3的2.5th和97.5th百分位数在按计算碘摄入或尿碘浓度分组间无显著差异。
临床怎么用
- 孕期应关注碘营养状态,尿碘浓度可作为评估碘缺乏的指标。
- 轻中度碘缺乏可能影响甲状腺功能,但差异较小,解读甲状腺功能参考范围时需考虑碘缺乏背景。
- 妊娠12周后补碘需监测甲状腺功能,警惕暂时性激素降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies indicate that mild to moderate iodine deficiency in pregnancy may have a long-term negative impact on child neurodevelopment. These effects are likely mediated via changes in maternal thyroid function, since iodine is essential for the production of thyroid hormones. However, the impact of iodine availability on thyroid function during pregnancy and on thyroid function reference ranges are understudied. The aim of this study was to investigate the association between iodine intake and thyroid function during pregnancy. DESIGN: In a population-based pregnancy cohort including 2910 pregnant women participating in The Norwegian Mother and Child Cohort Study, we explored cross sectional associations of maternal iodine intake measured (1) by a food frequency questionnaire and (2) as iodine concentration in a spot urine sample, with plasma thyroid hormones and antibodies. RESULTS: Biological samples were collected in mean gestational week 18.5 (standard deviation 1.3) and diet was assessed in gestational week 22. Median iodine intake from food was 121 μg/day (interquartile range 90, 160), and 40% reported use of iodine-containing supplements in pregnancy. Median urinary iodine concentration (UIC) was 59 μg/L among those who did not use supplements and 98 μg/L in the women reporting current use at the time of sampling, indicating mild to moderate iodine deficiency in both groups. Iodine intake as measured by the food frequency questionnaire was not associated with the outcome measures, while UIC was inversely associated with FT3 (p = 0.002) and FT4 (p < 0.001). Introduction of an iodine-containing supplement after gestational week 12 was associated with indications of lower thyroid hormone production (lower FT4, p = 0.027, and nonsignificantly lower FT3, p = 0.17). The 2.5th and 97.5th percentiles of TSH, FT4, and FT3 were not significantly different by groups defined by calculated iodine intake or by UIC. CONCLUSION: The results indicate that mild to moderate iodine deficiency affect thyroid function in pregnancy. However, the differences were small, suggesting that normal reference ranges can be determined based on data also from mildly iodine deficient populations, but this needs to be further studied. Introducing an iodine-containing supplement might temporarily inhibit thyroid hormone production and/or release.
引用
- Abel MH, Korevaar TIM, Erlund I, et al. Iodine Intake is Associated with Thyroid Function in Mild to Moderately Iodine Deficient Pregnant Women. Thyroid. 2018. PMID: 30132420. doi:10.1089/thy.2018.0305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。